-
1دورية أكاديمية
المؤلفون: Levine, Lauren S, Mahuron, Kelly M, Tsai, Katy K, Wu, Clinton, Mattis, Daiva M, Pauli, Mariela L, Oglesby, Arielle, Lee, James C, Spitzer, Matthew H, Krummel, Matthew F, Algazi, Alain P, Rosenblum, Michael D, Alvarado, Michael, Daud, Adil I
المصدر: Annals of Surgical Oncology. 27(11)
مصطلحات موضوعية: Biomedical and Clinical Sciences, Oncology and Carcinogenesis, Immunology, Patient Safety, Cancer, Immunization, Clinical Research, Vaccine Related, CTLA-4 Antigen, Humans, Immune Checkpoint Inhibitors, Immunotherapy, Kaplan-Meier Estimate, Melanoma, Neoadjuvant Therapy, Programmed Cell Death 1 Receptor, Tumor Microenvironment, Oncology & Carcinogenesis, Oncology and carcinogenesis
وصف الملف: application/pdf
الوصول الحر: https://escholarship.org/uc/item/2tv559t6Test
-
2دورية أكاديمية
المؤلفون: Pai, Chien-Chun Steven, Huang, John T, Lu, Xiaoqing, Simons, Donald M, Park, Chanhyuk, Chang, Anthony, Tamaki, Whitney, Liu, Eric, Roybal, Kole T, Seagal, Jane, Chen, Mingyi, Hagihara, Katsunobu, Wei, Xiao X, DuPage, Michel, Kwek, Serena S, Oh, David Y, Daud, Adil, Tsai, Katy K, Wu, Clint, Zhang, Li, Fasso, Marcella, Sachidanandam, Ravi, Jayaprakash, Anitha, Lin, Ingrid, Casbon, Amy-Jo, Kinsbury, Gillian A, Fong, Lawrence
المصدر: Immunity. 50(2)
مصطلحات موضوعية: T-Lymphocytes, Cell Line, Tumor, Animals, Mice, Inbred C57BL, Mice, Knockout, Humans, Neoplasms, Experimental, Antibodies, Monoclonal, Tumor Burden, Clonal Deletion, Drug Resistance, Neoplasm, Male, Interferon-gamma, CTLA-4 Antigen, Programmed Cell Death 1 Receptor, IFN-γ, activation-induced cell death, anti-CTLA-4, anti-PD-1, cancer, immunotherapy, Immunization, Cancer, Vaccine Related, Development of treatments and therapeutic interventions, 5.1 Pharmaceuticals, Inflammatory and immune system, Immunology
وصف الملف: application/pdf
الوصول الحر: https://escholarship.org/uc/item/3vt866nqTest
-
3دورية أكاديمية
المؤلفون: Loo, Kimberly, Tsai, Katy K, Mahuron, Kelly, Liu, Jacqueline, Pauli, Mariela L, Sandoval, Priscila M, Nosrati, Adi, Lee, James, Chen, Lawrence, Hwang, Jimmy, Levine, Lauren S, Krummel, Matthew F, Algazi, Alain P, Pampaloni, Miguel, Alvarado, Michael D, Rosenblum, Michael D, Daud, Adil I
المصدر: JCI Insight. 2(14)
مصطلحات موضوعية: Biomedical and Clinical Sciences, Oncology and Carcinogenesis, Immunology, Clinical Research, Immunization, Vaccine Related, Cancer, Cancer immunotherapy, Dermatology, Melanoma, Oncology, T cells, Biomedical and clinical sciences, Health sciences
وصف الملف: application/pdf
الوصول الحر: https://escholarship.org/uc/item/6p96p60jTest
-
4دورية أكاديمية
المؤلفون: Tsai, Katy K, Pampaloni, Miguel H, Hope, Charity, Algazi, Alain P, Ljung, Britt-Marie, Pincus, Laura, Daud, Adil I
المصدر: Journal for ImmunoTherapy of Cancer. 4(1)
مصطلحات موضوعية: Immunization, Biomedical Imaging, Cancer, 4.2 Evaluation of markers and technologies, Detection, screening and diagnosis, Immunotherapy, Biomarker, PD-1, CTLA-4, PET/CT
وصف الملف: application/pdf
الوصول الحر: https://escholarship.org/uc/item/7vx0v09hTest
-
5دورية أكاديمية
المؤلفون: Tsai, Katy K, Daud, Adil I
المصدر: Journal of Hematology & Oncology. 8(1)
مصطلحات موضوعية: Immunization, Cancer, Antibodies, Monoclonal, Antineoplastic Combined Chemotherapy Protocols, Clinical Trials, Phase III as Topic, Disease-Free Survival, Double-Blind Method, Drug Administration Schedule, Follow-Up Studies, Humans, Ipilimumab, Melanoma, Multicenter Studies as Topic, Nivolumab, Randomized Controlled Trials as Topic, Skin Neoplasms, Treatment Outcome, Immunotherapy, PD-1, CTLA-4, Cardiorespiratory Medicine and Haematology, Oncology and Carcinogenesis
وصف الملف: application/pdf
الوصول الحر: https://escholarship.org/uc/item/18s7b110Test
-
6دورية أكاديمية
المؤلفون: Tsai, Katy K, Zarzoso, Inés, Daud, Adil I
المصدر: Human Vaccines & Immunotherapeutics. 10(11)
مصطلحات موضوعية: Cancer, Immunization, Climate-Related Exposures and Conditions, Antibodies, Monoclonal, Antibodies, Monoclonal, Humanized, Antineoplastic Agents, B7-H1 Antigen, CTLA-4 Antigen, Humans, Immunotherapy, Lymphocyte Activation, Melanoma, Nivolumab, Programmed Cell Death 1 Receptor, T-Lymphocytes, BMS-936559, PD-1, PD-L1, PD-L2, immunotherapy, MPDL3280A, melanoma, nivolumab, pembrolizumab, AE, adverse event, APC, antigen presenting cell, ASCO, American Society of Clinical Oncology, CTLA-4, cytotoxic T-lymphocyte-associated protein 4, FDA, Food and Drug Administration, gp100, glycoprotein 100 vaccine, Ig, immunoglobulin, ITIM, immunoreceptor tyrosine-based inhibitory motif, ITSM, immunoreceptor tyrosine-based switch motif, MAPK, mitogen-activated protein kinase, MHC, major histocompatibility complex, NK, natural killer, ORR, objective response rate, OS, overall survival, PD, progressive disease, programmed cell death 1, programmed cell death ligand 1, PFS, progression free survival, TCR, T cell receptor, TIL, tumor infiltrating lymphocyte, AE, adverse event, APC, antigen presenting cell, ASCO, American Society of Clinical Oncology, CTLA-4, cytotoxic T-lymphocyte-associated protein 4, FDA, Food and Drug Administration, ITIM, immunoreceptor tyrosine-based inhibitory motif, ITSM, immunoreceptor tyrosine-based switch motif, Ig, immunoglobulin, MAPK, mitogen-activated protein kinase, MHC, major histocompatibility complex, NK, natural killer, ORR, objective response rate, OS, overall survival, PD, progressive disease, PD-1, programmed cell death 1, PD-L1, programmed cell death ligand 1, PFS, progression free survival, TCR, T cell receptor, TIL, tumor infiltrating lymphocyte, gp100, glycoprotein 100 vaccine, Immunology, Medical Microbiology, Pharmacology and Pharmaceutical Sciences, Virology
وصف الملف: application/pdf
الوصول الحر: https://escholarship.org/uc/item/49q8w2djTest